Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 52 results found. Search for [ Sinovac Biotech ]

Results 1 to 21 of 52
Reuters
November 11, 2020
The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data


BusinessToday.In
November 11, 2020
Coronavirus vaccine: India will focus on these two vaccines as they are being tested on the Indian population and hence has a major advantage over other potential candidates


Reuters
November 10, 2020
Under Bingham's leadership, the taskforce has secured supply deals for more than 350 million doses of six different COVID-19 vaccine candidates, including the Pfizer shot


BusinessToday.In
October 16, 2020
In these tightly-controlled trials, volunteers will be given a vaccine and then about a month later they will deliberately be infected with COVID-19 under controlled conditions


BusinessToday.In
October 16, 2020
In these tightly-controlled trials, volunteers will be given a vaccine and then about a month later they will deliberately be infected with COVID-19 under controlled conditions


Reuters
October 14, 2020
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as tantamount to a cure in a video he posted last week


Reuters
October 14, 2020
The country's state medical research agency had given a go-ahead to the Phase III trial in July and government approval came a month later


BusinessToday.In
October 13, 2020
Bangladesh has rejected the clinical trial of an experimental Chinese coronavirus vaccine which was being developed by Sinovac Biotech in the country


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


Reuters
September 26, 2020
China launched its emergency programme in July, having communicated with the WHO in late June, according to Zheng Zhongwei, a National Health Commission official


Reuters
September 16, 2020
China launched a vaccine emergency use programme in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech


Reuters
September 15, 2020
A unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech are developing the three vaccines under the state's emergency use programme


BusinessToday.In
September 9, 2020
Dr VK Paul informed the Russian government has approached India to facilitate the Phase-3 trial of their vaccine and also manufacture Sputnik V through Indian companies


Reuters
September 8, 2020
Health officials have been concerned about whether experimental vaccines could safely protect the elderly, whose immune systems usually react less robustly to vaccines, against the virus that has led to nearly 890,000 deaths worldwide


Reuters
September 6, 2020
The extent of inoculations under the emergency program, which China launched in July but has released few details about, points to how actively it is using experimental vaccines in the hopes of protecting essential workers against a potential COVID-19 resurgence


BusinessToday.In
September 4, 2020
Coronavirus vaccine update: Even as drugmakers worldwide race against time, the final data on whether a vaccine can prevent people from getting infected will only come by the middle of September


Reuters
September 3, 2020
Michael Osterholm, a University of Minnesota infectious disease expert, said he was concerned about an \"October surprise\" with a vaccine being rushed through ahead of the election


BusinessToday.In
September 1, 2020
COVID-19 vaccine: The University of Oxford and AstraZeneca PLC has developed the first vaccine candidate to start the final round of testing of the coronavirus vaccine


Reuters
August 29, 2020
The company is working on two of the more than 150 potential vaccines being developed across the world to tackle the COVID-19 pandemic


Reuters
August 29, 2020
Beximco will be the exclusive supplier in Bangladesh for the vaccine being developed by Serum Institute of India (SII), both companies said in a statement on Friday


PAGES 1 OF 3  123